IgM and IgG Antibodies after Lung Transplantation
Author Information
Author(s): Annelieke W. M. Paantjens, Ed A. van de Graaf, Johanna M. Kwakkel-van Erp, Tineke Hoefnagel, Walter G. J. van Ginkel, Farzia Fakhry, Diana A. van Kessel, Jules M. M. van den Bosch, Henny G. Otten
Primary Institution: University Medical Centre Utrecht
Hypothesis
The study investigates the relationship between IgM and IgG antibodies against HLA and MICA after lung transplantation.
Conclusion
The presence of IgM and IgG antibodies is not related to the development of bronchiolitis obliterans syndrome (BOS) after lung transplantation.
Supporting Evidence
- Patients with elevated IgM antibodies did not show a correlation with the development of BOS.
- High levels of IgM antibodies were observed more frequently in patients with BOS compared to those without.
- Low levels of IgG antibodies were detected in patients diagnosed with BOS.
Takeaway
Doctors looked at blood from lung transplant patients to see if certain antibodies could predict problems later, but they found that these antibodies didn't really help with that.
Methodology
Serum was collected from 49 patients before and after lung transplantation and analyzed for IgM and IgG antibodies using Luminex.
Potential Biases
Potential bias due to the lack of randomization and the observational nature of the study.
Limitations
The study did not include standard surveillance bronchoscopies and relied on patient-reported outcomes for lung function decline.
Participant Demographics
Patients were lung transplant recipients with a mix of primary diseases including cystic fibrosis, emphysema, and fibrotic diseases.
Statistical Information
P-Value
0.02
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website